Aiding and Abetting Anhedonia: Impact of Inflammation on the Brain and Pharmacological Implications
Tóm tắt
Từ khóa
Tài liệu tham khảo
aan het Rot, 2010, Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression, Biol Psychiat, 67, 139, 10.1016/j.biopsych.2009.08.038
Abdallah, 2020, Modulation of the antidepressant effects of ketamine by the mTORC1 inhibitor rapamycin, Neuropsychopharmacology, 45, 990, 10.1038/s41386-020-0644-9
Abud, 2017, iPSC-derived human microglia-like cells to study neurological diseases, Neuron, 94, 278, 10.1016/j.neuron.2017.03.042
Al Shirawi, 2017, Brexpiprazole in the treatment of major depressive disorder, Clin Med Ther, 9, 1
AlAsfoor, 2018, Imatinib reduces non-alcoholic fatty liver disease in obese mice by targeting inflammatory and lipogenic pathways in macrophages and liver, Sci Rep, 8, 15331, 10.1038/s41598-018-32853-w
Ambrósio, 2018, Depression and peripheral inflammatory profile of patients with obesity, Psychoneuroendocrinology, 91, 132, 10.1016/j.psyneuen.2018.03.005
Anderson A, Iosifescu DV, Jacobson M, Jones A, Kennon K, O’Gorman C, Stahl SM, and Tabuteau H (2019) Efficacy and safety of AXS-05, an oral NMDA receptor antagonist with multimodal activity, in major depressive disorder: results of a phase 2, double-blind, active-controlled trial. W43, in ASCP Annual Meeting; 2019 May 29; Scottsdale, AZ; pp 28–31.
Andican, 2012, Plasma oxidative and inflammatory markers in patients with idiopathic parkinson’s disease, Acta Neurol Belg, 112, 155, 10.1007/s13760-012-0015-3
Arteaga-Henríquez, 2019, Low-grade inflammation as a predictor of antidepressant and anti-inflammatory therapy response in MDD patients: a systematic review of the literature in combination with an analysis of experimental data collected in the EU-MOODINFLAME consortium, Front Psychiatry, 10, 458, 10.3389/fpsyt.2019.00458
Attwells, 2020, Translocator protein distribution volume predicts reduction of symptoms during open-label trial of celecoxib in major depressive disorder, Biol Psychiatry, 88, 649, 10.1016/j.biopsych.2020.03.007
Banasr, 2010, Glial pathology in an animal model of depression: reversal of stress-induced cellular, metabolic and behavioral deficits by the glutamate-modulating drug riluzole, Mol Psychiatry, 15, 501, 10.1038/mp.2008.106
Bantug, 2018, The spectrum of T cell metabolism in health and disease, Nat Rev Immunol, 18, 19, 10.1038/nri.2017.99
Baranyi, 2018, Metabolomics approach in the investigation of depression biomarkers in pharmacologically induced immune-related depression, PLoS One, 13, 10.1371/journal.pone.0208238
Barbosa, 2020, Probiotics and prebiotics: focus on psychiatric disorders - a systematic review, Nutr Rev, 78, 437, 10.1093/nutrit/nuz080
Baudino, 2015, Targeted cancer therapy: the next generation of cancer treatment, Curr Drug Discov Technol, 12, 3, 10.2174/1570163812666150602144310
Bechtholt-Gompf, 2010, Blockade of astrocytic glutamate uptake in rats induces signs of anhedonia and impaired spatial memory, Neuropsychopharmacology, 35, 2049, 10.1038/npp.2010.74
Bekhbat, 2018, Glucose and lipid-related biomarkers and the antidepressant response to infliximab in patients with treatment-resistant depression, Psychoneuroendocrinology, 98, 222, 10.1016/j.psyneuen.2018.09.004
Bekhbat, 2020, Gene signatures in peripheral blood immune cells related to insulin resistance and low tyrosine metabolism define a sub-type of depression with high CRP and anhedonia, Brain Behav Immun, 88, 161, 10.1016/j.bbi.2020.03.015
Benes, 2011, Ropinirole improves depressive symptoms and restless legs syndrome severity in RLS patients: a multicentre, randomized, placebo-controlled study, J Neurol, 258, 1046, 10.1007/s00415-010-5879-7
Berk, 2013, So depression is an inflammatory disease, but where does the inflammation come from?, BMC Med, 11, 200, 10.1186/1741-7015-11-200
Berk, 2020, Effect of aspirin vs placebo on the prevention of depression in older people: a randomized clinical trial, JAMA Psychiatry, 77, 1012, 10.1001/jamapsychiatry.2020.1214
Berman, 2000, Antidepressant effects of ketamine in depressed patients, Biol Psychiatry, 47, 351, 10.1016/S0006-3223(99)00230-9
Berman, 2009, Aripiprazole augmentation in major depressive disorder: a double-blind, placebo-controlled study in patients with inadequate response to antidepressants, CNS Spectr, 14, 197, 10.1017/S1092852900020216
Berman, 2007, The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a multicenter, randomized, double-blind, placebo-controlled study, J Clin Psychiatry, 68, 843, 10.4088/JCP.v68n0604
Berridge, 2007, The debate over dopamine’s role in reward: the case for incentive salience, Psychopharmacology (Berl), 191, 391, 10.1007/s00213-006-0578-x
Bersano, 2008, Recovery after L-DOPA treatment in peginterferon and ribavirin induced parkinsonism, Eur J Intern Med, 19, 370, 10.1016/j.ejim.2007.10.003
Bessler, 1999, IL-1β, IL-2, IL-6 AND TNF-α production by peripheral blood mononuclear cells from patients with parkinson's disease, Biomedicine & Pharmacotherapy, 53, 141, 10.1016/S0753-3322(99)80079-1
Bezzi, 2001, CXCR4-activated astrocyte glutamate release via TNFalpha: amplification by microglia triggers neurotoxicity, Nat Neurosci, 4, 702, 10.1038/89490
Bonaccorso, 2002, Increased depressive ratings in patients with hepatitis C receiving interferon-alpha-based immunotherapy are related to interferon-alpha-induced changes in the serotonergic system, J Clin Psychopharmacol, 22, 86, 10.1097/00004714-200202000-00014
Bower, 2019, The role of neuro-immune interactions in cancer-related fatigue: biobehavioral risk factors and mechanisms, Cancer, 125, 353, 10.1002/cncr.31790
Boyle, 2019, Inflammation and dimensions of reward processing following exposure to the influenza vaccine, Psychoneuroendocrinology, 102, 16, 10.1016/j.psyneuen.2018.11.024
Bremner, 2020, Transcutaneous vagal nerve stimulation blocks stress-induced activation of Interleukin-6 and interferon-γ in posttraumatic stress disorder: a double-blind, randomized, sham-controlled trial, Brain Behav Immun Health, 9
Brydon, 2008, Peripheral inflammation is associated with altered substantia nigra activity and psychomotor slowing in humans, Biol Psychiatry, 63, 1022, 10.1016/j.biopsych.2007.12.007
Buntinx, 2004, Cytokine-induced cell death in human oligodendroglial cell lines: I. synergistic effects of IFN-gamma and TNF-alpha on apoptosis, J Neurosci Res, 76, 834, 10.1002/jnr.20118
Cai, 2020, Minocycline for depressive symptoms: a meta-analysis of randomized, double-blinded, placebo-controlled trials, Psychiatr Q, 91, 451, 10.1007/s11126-019-09707-3
Capuron, 2009, Does cytokine-induced depression differ from idiopathic major depression in medically healthy individuals?, J Affect Disord, 119, 181, 10.1016/j.jad.2009.02.017
Capuron, 2002, Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions, Neuropsychopharmacology, 26, 643, 10.1016/S0893-133X(01)00407-9
Capuron, 2004, Cytokines and psychopathology: lessons from interferon-alpha, Biol Psychiatry, 56, 819, 10.1016/j.biopsych.2004.02.009
Capuron, 2003, Interferon-alpha-induced changes in tryptophan metabolism. relationship to depression and paroxetine treatment, Biol Psychiatry, 54, 906, 10.1016/S0006-3223(03)00173-2
Capuron, 2005, Anterior cingulate activation and error processing during interferon-alpha treatment, Biol Psychiatry, 58, 190, 10.1016/j.biopsych.2005.03.033
Capuron, 2007, Basal ganglia hypermetabolism and symptoms of fatigue during interferon-alpha therapy, Neuropsychopharmacology, 32, 2384, 10.1038/sj.npp.1301362
Capuron, 2012, Dopaminergic mechanisms of reduced basal ganglia responses to hedonic reward during interferon alfa administration, Arch Gen Psychiatry, 69, 1044, 10.1001/archgenpsychiatry.2011.2094
Capuron, 2002, Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy, Mol Psychiatry, 7, 468, 10.1038/sj.mp.4000995
Capuron, 2011, Chronic low-grade inflammation in elderly persons is associated with altered tryptophan and tyrosine metabolism: role in neuropsychiatric symptoms, Biol Psychiatry, 70, 175, 10.1016/j.biopsych.2010.12.006
Capuron, 2008, Depressive symptoms and metabolic syndrome: is inflammation the underlying link?, Biol Psychiatry, 64, 896, 10.1016/j.biopsych.2008.05.019
Carboni, 1990, Blockade of the noradrenaline carrier increases extracellular dopamine concentrations in the prefrontal cortex: evidence that dopamine is taken up in vivo by noradrenergic terminals, J Neurochem, 55, 1067, 10.1111/j.1471-4159.1990.tb04599.x
Castillo, 2000, Proton MR spectroscopy in children with bipolar affective disorder: preliminary observations, AJNR Am J Neuroradiol, 21, 832
Cattaneo, 2020, Whole-blood expression of inflammasome- and glucocorticoid-related mRNAs correctly separates treatment-resistant depressed patients from drug-free and responsive patients in the BIODEP study, Transl Psychiatry, 10, 232, 10.1038/s41398-020-00874-7
Cattaneo, 2016, Absolute measurements of macrophage migration inhibitory factor and interleukin-1-β mRNA levels accurately predict treatment response in depressed patients, Int J Neuropsychopharmacol, 19, pyw045, 10.1093/ijnp/pyw045
Cattaneo, 2013, Candidate genes expression profile associated with antidepressants response in the GENDEP study: differentiating between baseline 'predictors' and longitudinal 'targets', Neuropsychopharmacology, 38, 377, 10.1038/npp.2012.191
Chamberlain, 2019, Treatment-resistant depression and peripheral C-reactive protein, Br J Psychiatry, 214, 11, 10.1192/bjp.2018.66
Chen, 2017, TNFAIP3 mRNA level is associated with psychological anxiety in major depressive disorder, Neuroimmunomodulation, 24, 271, 10.1159/000486860
Christ, 2019, The Western lifestyle has lasting effects on metaflammation, Nat Rev Immunol, 19, 267, 10.1038/s41577-019-0156-1
Clayton, 2006, Bupropion extended release compared with escitalopram: effects on sexual functioning and antidepressant efficacy in 2 randomized, double-blind, placebo-controlled studies, J Clin Psychiatry, 67, 736, 10.4088/JCP.v67n0507
Clowry, 2010, Renewed focus on the developing human neocortex, J Anat, 217, 276, 10.1111/j.1469-7580.2010.01281.x
Cooper, 2018, Anhedonia in depression: biological mechanisms and computational models, Curr Opin Behav Sci, 22, 128, 10.1016/j.cobeha.2018.01.024
Corrigan, 2000, Comparison of pramipexole, fluoxetine, and placebo in patients with major depression, Depress Anxiety, 11, 58, 10.1002/(SICI)1520-6394(2000)11:2<58::AID-DA2>3.0.CO;2-H
Costello, 2019, Systematic review and meta-analysis of the association between peripheral inflammatory cytokines and generalised anxiety disorder, BMJ Open, 9, 10.1136/bmjopen-2018-027925
Cusin, 2013, A randomized, double-blind, placebo-controlled trial of pramipexole augmentation in treatment-resistant major depressive disorder, J Clin Psychiatry, 74, e636, 10.4088/JCP.12m08093
Cuthbert, 2015, Research Domain Criteria: toward future psychiatric nosologies, Dialogues Clin Neurosci, 17, 89, 10.31887/DCNS.2015.17.1/bcuthbert
Da Mesquita, 2018, The meningeal lymphatic system: a new player in neurophysiology, Neuron, 100, 375, 10.1016/j.neuron.2018.09.022
Dai, 2010, Indoleamine 2,3-dioxygenase tissue distribution and cellular localization in mice: implications for its biological functions, J Histochem Cytochem, 58, 17, 10.1369/jhc.2009.953604
Davies, 2020, Interferon and anti-TNF therapies differentially modulate amygdala reactivity which predicts associated bidirectional changes in depressive symptoms, Mol Psychiatry
de Lartigue, 2017, Hallmark tumor metabolism becomes a validated therapeutic target, J Community Support Oncol, 15, e47, 10.12788/jcso.0389
Deakin, 2018, The benefit of minocycline on negative symptoms of schizophrenia in patients with recent-onset psychosis (BeneMin): a randomised, double-blind, placebo-controlled trial, Lancet Psychiatry, 5, 885, 10.1016/S2215-0366(18)30345-6
Dinan, 2019, Gut microbes and depression: still waiting for Godot, Brain Behav Immun, 79, 1, 10.1016/j.bbi.2019.02.007
Dowell, 2016, Acute changes in striatal microstructure predict the development of interferon-alpha induced fatigue, Biol Psychiatry, 79, 320, 10.1016/j.biopsych.2015.05.015
Dowlati, 2010, A meta-analysis of cytokines in major depression, Biol Psychiatry, 67, 446, 10.1016/j.biopsych.2009.09.033
Draper, 2018, Effort but not reward sensitivity is altered by acute sickness induced by experimental endotoxemia in humans, Neuropsychopharmacology, 43, 1107, 10.1038/npp.2017.231
Du, 2019, Minocycline ameliorates depressive-like behavior and demyelination induced by transient global cerebral ischemia by inhibiting microglial activation, Front Pharmacol, 10, 1247, 10.3389/fphar.2019.01247
Ducasse, 2020, Association between anhedonia and suicidal events in patients with mood disorders: a 3-year prospective study, Depress Anxiety, 38, 17, 10.1002/da.23072
Ducasse, 2018, Anhedonia is associated with suicidal ideation independently of depression: a meta-analysis, Depress Anxiety, 35, 382, 10.1002/da.22709
Ducrocq, 2020, Causal Link between n-3 polyunsaturated fatty acid deficiency and motivation deficits, Cell Metab, 31, 755, 10.1016/j.cmet.2020.02.012
Dudek, 2020, Molecular adaptations of the blood-brain barrier promote stress resilience vs. depression, Proc Natl Acad Sci USA, 117, 3326, 10.1073/pnas.1914655117
Duman, 2012, Signaling pathways underlying the rapid antidepressant actions of ketamine, Neuropharmacology, 62, 35, 10.1016/j.neuropharm.2011.08.044
Dunlop, 2007, Coadministration of modafinil and a selective serotonin reuptake inhibitor from the initiation of treatment of major depressive disorder with fatigue and sleepiness: a double-blind, placebo-controlled study, J Clin Psychopharmacol, 27, 614, 10.1097/jcp.0b013e31815abefb
Eiraku, 2008, Self-organized formation of polarized cortical tissues from ESCs and its active manipulation by extrinsic signals, Cell Stem Cell, 3, 519, 10.1016/j.stem.2008.09.002
Eisenberger, 2010, Inflammation-induced anhedonia: endotoxin reduces ventral striatum responses to reward, Biol Psychiatry, 68, 748, 10.1016/j.biopsych.2010.06.010
Eller, 2009, Effects of bupropion augmentation on pro-inflammatory cytokines in escitalopram-resistant patients with major depressive disorder, J Psychopharmacol, 23, 854, 10.1177/0269881108091077
Enache, 2019, Markers of central inflammation in major depressive disorder: A systematic review and meta-analysis of studies examining cerebrospinal fluid, positron emission tomography and post-mortem brain tissue, Brain Behav Immun, 81, 24, 10.1016/j.bbi.2019.06.015
Ericsson, 1994, A functional anatomical analysis of central pathways subserving the effects of interleukin-1 on stress-related neuroendocrine neurons, J Neurosci, 14, 897, 10.1523/JNEUROSCI.14-02-00897.1994
Escalona, 2017, Pramipexole in Treatment Resistant-Depression, Possible Role of Inflammatory Cytokines, Neuropsychopharmacology, 42, 363, 10.1038/npp.2016.217
Färber, 2005, Dopamine and noradrenaline control distinct functions in rodent microglial cells, Mol Cell Neurosci, 29, 128, 10.1016/j.mcn.2005.01.003
Fava, 2012, A double-blind, placebo-controlled study of aripiprazole adjunctive to antidepressant therapy among depressed outpatients with inadequate response to prior antidepressant therapy (ADAPT-A Study), Psychother Psychosom, 81, 87, 10.1159/000332050
Fava, 2005, A multicenter, placebo-controlled study of modafinil augmentation in partial responders to selective serotonin reuptake inhibitors with persistent fatigue and sleepiness, J Clin Psychiatry, 66, 85, 10.4088/JCP.v66n0112
Fawcett, 2016, Clinical experience with high-dosage pramipexole in patients with treatment-resistant depressive episodes in unipolar and bipolar depression, Am J Psychiatry, 173, 107, 10.1176/appi.ajp.2015.15060788
Feigin, 2001, Metabolic correlates of levodopa response in Parkinson’s disease, Neurology, 57, 2083, 10.1212/WNL.57.11.2083
Felger, 2012, Cytokine effects on the basal ganglia and dopamine function: The subcortical source of inflammatory malaise, Front Neuroendocrinol, 33, 315, 10.1016/j.yfrne.2012.09.003
Felger, 2007, Effects of interferon-alpha on rhesus monkeys: a nonhuman primate model of cytokine-induced depression, Biol Psychiatry, 62, 1324, 10.1016/j.biopsych.2007.05.026
Felger, 2020, What does plasma CRP tell us about peripheral and central inflammation in depression?, Mol Psychiatry, 25, 1301, 10.1038/s41380-018-0096-3
Felger, 2015, Levodopa reverses cytokine-induced reductions in striatal dopamine release, Int J Neuropsychopharmacol, 18, 18, 10.1093/ijnp/pyu084
Felger, 2013, Tyrosine metabolism during interferon-alpha administration: association with fatigue and CSF dopamine concentrations, Brain Behav Immun, 31, 153, 10.1016/j.bbi.2012.10.010
Felger, 2016, Inflammation is associated with decreased functional connectivity within corticostriatal reward circuitry in depression, Mol Psychiatry, 21, 1358, 10.1038/mp.2015.168
Felger, 2020, Identifying immunophenotypes of inflammation in depression: dismantling the monolith, Biol Psychiatry, 88, 136, 10.1016/j.biopsych.2020.04.024
Felger, 2013, Chronic interferon-alpha decreases dopamine 2 receptor binding and striatal dopamine release in association with anhedonia-like behavior in nonhuman primates, Neuropsychopharmacology, 38, 2179, 10.1038/npp.2013.115
Felger, 2017, Inflammation effects on motivation and motor activity: role of dopamine, Neuropsychopharmacology, 42, 216, 10.1038/npp.2016.143
Fleshner, 2017, Exosomes, DAMPs and miRNA: features of stress physiology and immune homeostasis, Trends Immunol, 38, 768, 10.1016/j.it.2017.08.002
Fleshner, 1998, Thermogenic and corticosterone responses to intravenous cytokines (IL-1beta and TNF-alpha) are attenuated by subdiaphragmatic vagotomy, J Neuroimmunol, 86, 134, 10.1016/S0165-5728(98)00026-5
Fortunato, 2018, An update on patents covering agents that interfere with the cancer glycolytic cascade, ChemMedChem, 13, 2251, 10.1002/cmdc.201800447
Franco-Chaves, 2013, Combining a dopamine agonist and selective serotonin reuptake inhibitor for the treatment of depression: a double-blind, randomized pilot study, J Affect Disord, 149, 319, 10.1016/j.jad.2013.02.003
Franzen, 2020, Cerebrospinal fluid proteome evaluation in major depressive disorder by mass spectrometry, BMC Psychiatry, 20, 481, 10.1186/s12888-020-02874-9
Frye, 2007, Increased anterior cingulate/medial prefrontal cortical glutamate and creatine in bipolar depression, Neuropsychopharmacology, 32, 2490, 10.1038/sj.npp.1301387
Fu, 2020, Esketamine nasal spray for rapid reduction of major depressive disorder symptoms in patients who have active suicidal ideation with intent: double-blind, randomized study (ASPIRE I), J Clin Psychiatry, 81, 19m13191, 10.4088/JCP.19m13191
Fulton, 2006, Leptin regulation of the mesoaccumbens dopamine pathway, Neuron, 51, 811, 10.1016/j.neuron.2006.09.006
Fumagalli, 2008, Riluzole enhances the activity of glutamate transporters GLAST, GLT1 and EAAC1, Eur J Pharmacol, 578, 171, 10.1016/j.ejphar.2007.10.023
Furman, 2019, Chronic inflammation in the etiology of disease across the life span, Nat Med, 25, 1822, 10.1038/s41591-019-0675-0
Ganeshan, 2014, Metabolic regulation of immune responses, Annu Rev Immunol, 32, 609, 10.1146/annurev-immunol-032713-120236
Garrido-Mesa, 2013, Minocycline: far beyond an antibiotic, Br J Pharmacol, 169, 337, 10.1111/bph.12139
Garza, 2020, Gamma visual stimulation induces a neuroimmune signaling profile distinct from acute neuroinflammation, J Neurosci, 40, 1211, 10.1523/JNEUROSCI.1511-19.2019
Gershon, 2019, Ropinirole augmentation for depression: a randomized controlled trial pilot study, J Clin Psychopharmacol, 39, 78, 10.1097/JCP.0000000000000984
Giacobbe, 2018, Efficacy and tolerability of lisdexamfetamine as an antidepressant augmentation strategy: A meta-analysis of randomized controlled trials, J Affect Disord, 226, 294, 10.1016/j.jad.2017.09.041
Glaus, 2015, Aspirin and statin use and the subsequent development of depression in men and women: results from a longitudinal population-based study, J Affect Disord, 182, 126, 10.1016/j.jad.2015.03.044
Godfrey, 2020, Obesogenic diet-associated C-reactive protein predicts reduced central dopamine and corticostriatal functional connectivity in female rhesus monkeys, Brain Behav Immun, 88, 166, 10.1016/j.bbi.2020.03.030
Goldsmith, 2020, Protein and gene markers of metabolic dysfunction and inflammation together associate with functional connectivity in reward and motor circuits in depression, Brain Behav Immun, 88, 193, 10.1016/j.bbi.2020.05.013
Goldsmith, 2018, TNF-α and IL-6 are associated with the deficit syndrome and negative symptoms in patients with chronic schizophrenia, Schizophr Res, 199, 281, 10.1016/j.schres.2018.02.048
Goldsmith, 2020, Inflammatory markers are associated with psychomotor slowing in patients with schizophrenia compared to healthy controls, NPJ Schizophr, 6, 8, 10.1038/s41537-020-0098-4
Goldsmith, 2016, A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression, Mol Psychiatry, 21, 1696, 10.1038/mp.2016.3
Goldstein, 2009, Inflammation and the phenomenology, pathophysiology, comorbidity, and treatment of bipolar disorder: a systematic review of the literature, J Clin Psychiatry, 70, 1078, 10.4088/JCP.08r04505
Gottschalk, 2004, Imatinib (STI571)-mediated changes in glucose metabolism in human leukemia BCR-ABL-positive cells, Clin Cancer Res, 10, 6661, 10.1158/1078-0432.CCR-04-0039
Griffiths, 2017, Impact of ixekizumab treatment on depressive symptoms and systemic inflammation in patients with moderate-to-severe psoriasis: an integrated analysis of three phase 3 clinical studies, Psychother Psychosom, 86, 260, 10.1159/000479163
Grossert, 2019, Ketamine increases proliferation of human iPSC-derived neuronal progenitor cells via insulin-like growth factor 2 and independent of the NMDA receptor, Cells, 8, 1139, 10.3390/cells8101139
Guilloux, 2015, Testing the predictive value of peripheral gene expression for nonremission following citalopram treatment for major depression, Neuropsychopharmacology, 40, 701, 10.1038/npp.2014.226
Haber, 2003, The primate basal ganglia: parallel and integrative networks, J Chem Neuroanat, 26, 317, 10.1016/j.jchemneu.2003.10.003
Haber, 2010, The reward circuit: linking primate anatomy and human imaging, Neuropsychopharmacology, 35, 4, 10.1038/npp.2009.129
Hajebrahimi, 2014, The adapter proteins of TLRs, TRIF and MYD88, are upregulated in depressed individuals, Int J Psychiatry Clin Pract, 18, 41, 10.3109/13651501.2013.859708
Hamer, 2019, Brain insulin resistance: a treatment target for cognitive impairment and anhedonia in depression, Exp Neurol, 315, 1, 10.1016/j.expneurol.2019.01.016
Hamidi, 2004, Glial reduction in amygdala in major depressive disorder is due to oligodendrocytes, Biol Psychiatry, 55, 563, 10.1016/j.biopsych.2003.11.006
Hansen, 2013, Non-epithelial stem cells and cortical interneuron production in the human ganglionic eminences, Nat Neurosci, 16, 1576, 10.1038/nn.3541
Hardingham, 2010, Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders, Nat Rev Neurosci, 11, 682, 10.1038/nrn2911
Haroon, 2018, Increased inflammation and brain glutamate define a subtype of depression with decreased regional homogeneity, impaired network integrity, and anhedonia, Transl Psychiatry, 8, 189, 10.1038/s41398-018-0241-4
Haroon, 2018, Antidepressant treatment resistance is associated with increased inflammatory markers in patients with major depressive disorder, Psychoneuroendocrinology, 95, 43, 10.1016/j.psyneuen.2018.05.026
Haroon, 2015, Age-related increases in basal ganglia glutamate are associated with TNF, reduced motivation and decreased psychomotor speed during IFN-alpha treatment: preliminary findings, Brain Behav Immun, 46, 17, 10.1016/j.bbi.2014.12.004
Haroon, 2016, Conceptual convergence: increased inflammation is associated with increased basal ganglia glutamate in patients with major depression, Mol Psychiatry, 21, 1351, 10.1038/mp.2015.206
Haroon, 2017, Inflammation, glutamate, and glia: a trio of trouble in mood disorders, Neuropsychopharmacology, 42, 193, 10.1038/npp.2016.199
Haroon, 2012, Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior, Neuropsychopharmacology, 37, 137, 10.1038/npp.2011.205
Haroon, 2020, Associations among peripheral and central kynurenine pathway metabolites and inflammation in depression, Neuropsychopharmacology, 45, 998, 10.1038/s41386-020-0607-1
Haroon, 2014, IFN-alpha-induced cortical and subcortical glutamate changes assessed by magnetic resonance spectroscopy, Neuropsychopharmacology, 39, 1777, 10.1038/npp.2014.25
Harrison, 2009, Inflammation causes mood changes through alterations in subgenual cingulate activity and mesolimbic connectivity, Biol Psychiatry, 66, 407, 10.1016/j.biopsych.2009.03.015
Harrison, 2016, A neurocomputational account of how inflammation enhances sensitivity to punishments versus rewards, Biol Psychiatry, 80, 73, 10.1016/j.biopsych.2015.07.018
Hashimoto, 2007, Increased levels of glutamate in brains from patients with mood disorders, Biol Psychiatry, 62, 1310, 10.1016/j.biopsych.2007.03.017
Hassin-Baer, 2011, Is C-reactive protein level a marker of advanced motor and neuropsychiatric complications in parkinson’s disease?, J Neural Transm, 118, 539, 10.1007/s00702-010-0535-z
Hodge, 2019, Conserved cell types with divergent features in human versus mouse cortex, Nature, 573, 61, 10.1038/s41586-019-1506-7
Hommel, 2006, Leptin receptor signaling in midbrain dopamine neurons regulates feeding, Neuron, 51, 801, 10.1016/j.neuron.2006.08.023
Hori, 2016, Blood-based gene expression signatures of medication-free outpatients with major depressive disorder: integrative genome-wide and candidate gene analyses, Sci Rep, 6, 18776, 10.1038/srep18776
Hotamisligil, 2017, Foundations of immunometabolism and implications for metabolic health and disease, Immunity, 47, 406, 10.1016/j.immuni.2017.08.009
Howren, 2009, Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis, Psychosom Med, 71, 171, 10.1097/PSY.0b013e3181907c1b
Hu, 2005, Inhibition of COX-2 by celecoxib enhances glucocorticoid receptor function, Mol Psychiatry, 10, 426, 10.1038/sj.mp.4001644
Hu, 2020, Aspirin and other non-steroidal anti-inflammatory drugs and depression, anxiety, and stress-related disorders following a cancer diagnosis: a nationwide register-based cohort study, BMC Med, 18, 238, 10.1186/s12916-020-01709-4
Hung, 2014, Association between toll-like receptors expression and major depressive disorder, Psychiatry Res, 220, 283, 10.1016/j.psychres.2014.07.074
Hung, 2017, TNFAIP3, a negative regulator of the TLR signaling pathway, is a potential predictive biomarker of response to antidepressant treatment in major depressive disorder, Brain Behav Immun, 59, 265, 10.1016/j.bbi.2016.09.014
Husain, 2020, Minocycline and celecoxib as adjunctive treatments for bipolar depression: a multicentre, factorial design randomised controlled trial, Lancet Psychiatry, 7, 515, 10.1016/S2215-0366(20)30138-3
Ibrahim, 2012, Course of improvement in depressive symptoms to a single intravenous infusion of ketamine vs add-on riluzole: results from a 4-week, double-blind, placebo-controlled study, Neuropsychopharmacology, 37, 1526, 10.1038/npp.2011.338
Ida, 2008, Cytokine-induced enhancement of calcium-dependent glutamate release from astrocytes mediated by nitric oxide, Neurosci Lett, 432, 232, 10.1016/j.neulet.2007.12.047
Inagaki, 2015, The role of the ventral striatum in inflammatory-induced approach toward support figures, Brain Behav Immun, 44, 247, 10.1016/j.bbi.2014.10.006
Ionescu, 2020, Esketamine nasal spray for rapid reduction of depressive symptoms in patients with major depressive disorder who have active suicide ideation with intent: results of a phase 3, double-blind, randomized study (ASPIRE II), Int J Neuropsychopharmaco, 24, 22, 10.1093/ijnp/pyaa068
Jansen, 2016, Gene expression in major depressive disorder, Mol Psychiatry, 21, 339, 10.1038/mp.2015.57
Jha, 2017, Can C-reactive protein inform antidepressant medication selection in depressed outpatients? Findings from the CO-MED trial, Psychoneuroendocrinology, 78, 105, 10.1016/j.psyneuen.2017.01.023
Jiang, 2015, Altered fecal microbiota composition in patients with major depressive disorder, Brain Behav Immun, 48, 186, 10.1016/j.bbi.2015.03.016
Johnson, 2012, The inflammation highway: metabolism accelerates inflammatory traffic in obesity, Immunol Rev, 249, 218, 10.1111/j.1600-065X.2012.01151.x
Juengling, 2000, Prefrontal cortical hypometabolism during low-dose interferon alpha treatment, Psychopharmacology (Berl), 152, 383, 10.1007/s002130000549
Kahl, 2006, Cortisol, the cortisol-dehydroepiandrosterone ratio, and pro-inflammatory cytokines in patients with current major depressive disorder comorbid with borderline personality disorder, Biol Psychiatry, 59, 667, 10.1016/j.biopsych.2005.08.001
Kappelmann, 2018, Antidepressant activity of anti-cytokine treatment: a systematic review and meta-analysis of clinical trials of chronic inflammatory conditions, Mol Psychiatry, 23, 335, 10.1038/mp.2016.167
Karson, 2013, Chronic administration of infliximab (TNF-α inhibitor) decreases depression and anxiety-like behaviour in rat model of chronic mild stress, Basic Clin Pharmacol Toxicol, 112, 335, 10.1111/bcpt.12037
Kathuria, 2020, Transcriptomic landscape and functional characterization of induced pluripotent stem cell-derived cerebral organoids in schizophrenia, JAMA Psychiatry, 77, 745, 10.1001/jamapsychiatry.2020.0196
Kazazoglou, 1996, Differential responsiveness of late passage C-6 glial cells and advanced passages of astrocytes derived from aged mouse cerebral hemispheres to cytokines and growth factors: glutamine synthetase activity, Neurochem Res, 21, 609, 10.1007/BF02527760
Kazumori, 2004, Transforming growth factor-alpha directly augments histidine decarboxylase and vesicular monoamine transporter 2 production in rat enterochromaffin-like cells, Am J Physiol Gastrointest Liver Physiol, 286, G508, 10.1152/ajpgi.00269.2003
Kéri, 2014, Expression of Toll-Like Receptors in peripheral blood mononuclear cells and response to cognitive-behavioral therapy in major depressive disorder, Brain Behav Immun, 40, 235, 10.1016/j.bbi.2014.03.020
Kim, 2011, Role of excitatory amino acid transporter-2 (EAAT2) and glutamate in neurodegeneration: opportunities for developing novel therapeutics, J Cell Physiol, 226, 2484, 10.1002/jcp.22609
Kishi, 2017, A meta-analysis of memantine for depression, J Alzheimers Dis, 57, 113, 10.3233/JAD-161251
Kobayashi, 2013, Minocycline selectively inhibits M1 polarization of microglia, Cell Death Dis, 4, 10.1038/cddis.2013.54
Köhler-Forsberg, 2019, Efficacy of anti-inflammatory treatment on major depressive disorder or depressive symptoms: meta-analysis of clinical trials, Acta Psychiatr Scand, 139, 404, 10.1111/acps.13016
Köhler, 2017, Peripheral cytokine and chemokine alterations in depression: a meta-analysis of 82 studies, Acta Psychiatr Scand, 135, 373, 10.1111/acps.12698
Köhler, 2014, Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects: a systematic review and meta-analysis of randomized clinical trials, JAMA Psychiatry, 71, 1381, 10.1001/jamapsychiatry.2014.1611
Korn, 2005, Autoantigen specific T cells inhibit glutamate uptake in astrocytes by decreasing expression of astrocytic glutamate transporter GLAST: a mechanism mediated by tumor necrosis factor-alpha, FASEB J, 19, 1878, 10.1096/fj.05-3748fje
Kornberg, 2018, Dimethyl fumarate targets GAPDH and aerobic glycolysis to modulate immunity, Science, 360, 449, 10.1126/science.aan4665
Krügel, 2003, Basal and feeding-evoked dopamine release in the rat nucleus accumbens is depressed by leptin, Eur J Pharmacol, 482, 185, 10.1016/j.ejphar.2003.09.047
Kruse, 2019, Kynurenine metabolism and inflammation-induced depressed mood: a human experimental study, Psychoneuroendocrinology, 109, 104371, 10.1016/j.psyneuen.2019.104371
Kruse, 2018, Inflammation and improvement of depression following electroconvulsive therapy in treatment-resistant depression, J Clin Psychiatry, 79, 17m11597, 10.4088/JCP.17m11597
Kurokawa, 2018, The effect of fecal microbiota transplantation on psychiatric symptoms among patients with irritable bowel syndrome, functional diarrhea and functional constipation: an open-label observational study, J Affect Disord, 235, 506, 10.1016/j.jad.2018.04.038
Lacey, 2020, Adverse childhood experiences and adult inflammation: single adversity, cumulative risk and latent class approaches, Brain Behav Immun, 87, 820, 10.1016/j.bbi.2020.03.017
Lacourt, 2018, The high costs of low-grade inflammation: persistent fatigue as a consequence of reduced cellular-energy availability and non-adaptive energy expenditure, Front Behav Neurosci, 12, 78, 10.3389/fnbeh.2018.00078
Lai, 2009, Lipopolysaccharide mitagates methamphetamine-induced striatal dopamine depletion via modulating local TNF-alpha and dopamine transporter expression, J Neural Transm (Vienna), 116, 405, 10.1007/s00702-009-0204-2
Lamers, 2018, Metabolic and inflammatory markers: associations with individual depressive symptoms, Psychol Med, 48, 1102, 10.1017/S0033291717002483
Lancaster, 2013, Cerebral organoids model human brain development and microcephaly, Nature, 501, 373, 10.1038/nature12517
Larson, 2002, Behavioral and motivational effects of immune-system activation, J Gen Psychol, 129, 401, 10.1080/00221300209602104
Lasselin, 2020, Sick for science: experimental endotoxemia as a translational tool to develop and test new therapies for inflammation-associated depression, Mol Psychiatry
Lasselin, 2016, Lipopolysaccharide alters motivated behavior in a monetary reward task: a randomized trial, Neuropsychopharmacology, 42, 801, 10.1038/npp.2016.191
Le, 2018, Identification and replication of RNA-Seq gene network modules associated with depression severity, Transl Psychiatry, 8, 180, 10.1038/s41398-018-0234-3
Leday, 2018, Replicable and coupled changes in innate and adaptive immune gene expression in two case-control studies of blood microarrays in major depressive disorder, Biol Psychiatry, 83, 70, 10.1016/j.biopsych.2017.01.021
Lee, 2017, Recent advances in the inhibition of p38 MAPK as a potential strategy for the treatment of Alzheimer’s disease, Molecules, 22, 1287, 10.3390/molecules22081287
Lee, 2020, Efficacy of adjunctive infliximab vs. placebo in the treatment of anhedonia in bipolar I/II depression, Brain Behav Immun, 88, 631, 10.1016/j.bbi.2020.04.063
Lemke, 2006, Effects of the dopamine agonist pramipexole on depression, anhedonia and motor functioning in Parkinson’s disease, J Neurol Sci, 248, 266, 10.1016/j.jns.2006.05.024
Lercher, 2020, Systemic immunometabolism: challenges and opportunities, Immunity, 53, 496, 10.1016/j.immuni.2020.08.012
Letinic, 2001, Telencephalic origin of human thalamic GABAergic neurons, Nat Neurosci, 4, 931, 10.1038/nn0901-931
Lewerenz, 2013, The cystine/glutamate antiporter system x(c)(-) in health and disease: from molecular mechanisms to novel therapeutic opportunities, Antioxid Redox Signal, 18, 522, 10.1089/ars.2011.4391
Li, 2008, Tumor necrosis factor alpha mediates lipopolysaccharide-induced microglial toxicity to developing oligodendrocytes when astrocytes are present, J Neurosci, 28, 5321, 10.1523/JNEUROSCI.3995-07.2008
Li, 2009, Coordination of sonic hedgehog and Wnt signaling determines ventral and dorsal telencephalic neuron types from human embryonic stem cells, Development, 136, 4055, 10.1242/dev.036624
Liao, 2019, Efficacy of omega-3 PUFAs in depression: a meta-analysis, Transl Psychiatry, 9, 190, 10.1038/s41398-019-0515-5
Linck, 2012, AMPA glutamate receptors mediate the antidepressant-like effects of N-acetylcysteine in the mouse tail suspension test, Behav Pharmacol, 23, 171, 10.1097/FBP.0b013e3283512c3a
Liu, 2014, Towards a “metabolic” subtype of major depressive disorder: shared pathophysiological mechanisms may contribute to cognitive dysfunction, CNS Neurol Disord Drug Targets, 13, 1693, 10.2174/1871527313666141130204031
Liu, 2020, Peripheral cytokine levels and response to antidepressant treatment in depression: a systematic review and meta-analysis, Mol Psychiatry, 25, 339, 10.1038/s41380-019-0474-5
Liu, 2019, Prebiotics and probiotics for depression and anxiety: a systematic review and meta-analysis of controlled clinical trials, Neurosci Biobehav Rev, 102, 13, 10.1016/j.neubiorev.2019.03.023
Lizarraga, 2015, Vesicular monoamine transporter 2 and the acute and long-term response to 3,4-(±)-methylenedioxymethamphetamine, Toxicol Sci, 143, 209, 10.1093/toxsci/kfu222
Loas, 2016, Relationships between anhedonia, alexithymia, impulsivity, suicidal ideation, recent suicide attempt, C-reactive protein and serum lipid levels among 122 inpatients with mood or anxious disorders, Psychiatry Res, 246, 296, 10.1016/j.psychres.2016.09.056
Lotrich, 2013, Elevated ratio of arachidonic acid to long-chain omega-3 fatty acids predicts depression development following interferon-alpha treatment: relationship with interleukin-6, Brain Behav Immun, 31, 48, 10.1016/j.bbi.2012.08.007
Lynall, 2020, Peripheral blood cell-stratified subgroups of inflamed depression, Biol Psychiatry, 88, 185, 10.1016/j.biopsych.2019.11.017
Mac Giollabhui, 2020, The longitudinal associations of inflammatory biomarkers and depression revisited: systematic review, meta-analysis, and meta-regression, Mol Psychiatry
Madhoo, 2014, Lisdexamfetamine dimesylate augmentation in adults with persistent executive dysfunction after partial or full remission of major depressive disorder, Neuropsychopharmacology, 39, 1388, 10.1038/npp.2013.334
Maes, 1995, Evidence for an immune response in major depression: a review and hypothesis, Prog Neuropsychopharmacol Biol Psychiatry, 19, 11, 10.1016/0278-5846(94)00101-M
Maes, 1992, Higher alpha 1-antitrypsin, haptoglobin, ceruloplasmin and lower retinol binding protein plasma levels during depression: further evidence for the existence of an inflammatory response during that illness, J Affect Disord, 24, 183, 10.1016/0165-0327(92)90066-F
Manabe, 2000, Loss of cadherin-11 adhesion receptor enhances plastic changes in hippocampal synapses and modifies behavioral responses, Mol Cell Neurosci, 15, 534, 10.1006/mcne.2000.0849
Marcus, 2008, The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study, J Clin Psychopharmacol, 28, 156, 10.1097/JCP.0b013e31816774f9
Mariani, 2015, FOXG1-dependent dysregulation of GABA/glutamate neuron differentiation in autism spectrum disorders, Cell, 162, 375, 10.1016/j.cell.2015.06.034
Mariani, 2012, Modeling human cortical development in vitro using induced pluripotent stem cells, Proc Natl Acad Sci USA, 109, 12770, 10.1073/pnas.1202944109
Marshall, 2020, The lasting misery of coronavirus long-haulers, Nature, 585, 339, 10.1038/d41586-020-02598-6
Matt, 2020, Where is dopamine and how do immune cells see it?: dopamine-mediated immune cell function in health and disease, J Neuroimmune Pharmacol, 15, 114, 10.1007/s11481-019-09851-4
Matute, 2006, Glutamate-mediated glial injury: mechanisms and clinical importance, Glia, 53, 212, 10.1002/glia.20275
McCullumsmith, 2015, Regulation of extrasynaptic glutamate levels as a pathophysiological mechanism in disorders of motivation and addiction, Neuropsychopharmacology, 40, 254, 10.1038/npp.2014.218
McGirr, 2015, A systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials of ketamine in the rapid treatment of major depressive episodes, Psychol Med, 45, 693, 10.1017/S0033291714001603
McIntyre, 2019, Efficacy of adjunctive infliximab vs placebo in the treatment of adults with bipolar I/II depression: a randomized clinical trial, JAMA Psychiatry, 76, 783, 10.1001/jamapsychiatry.2019.0779
McKim, 2018, Microglial recruitment of IL-1β-producing monocytes to brain endothelium causes stress-induced anxiety, Mol Psychiatry, 23, 1421, 10.1038/mp.2017.64
Mehta, 2013, Transcriptional signatures related to glucose and lipid metabolism predict treatment response to the tumor necrosis factor antagonist infliximab in patients with treatment-resistant depression, Brain Behav Immun, 31, 205, 10.1016/j.bbi.2013.04.004
Mehta, 2018, Inflammation negatively correlates with amygdala-ventromedial prefrontal functional connectivity in association with anxiety in patients with depression: preliminary results, Brain Behav Immun, 73, 725, 10.1016/j.bbi.2018.07.026
Mehta, 2020, Inflammation, reward circuitry and symptoms of anhedonia and PTSD in trauma-exposed women, Soc Cogn Affect Neurosci, 15, 1046, 10.1093/scan/nsz100
Meiser, 2013, Complexity of dopamine metabolism, Cell Commun Signal, 11, 34, 10.1186/1478-811X-11-34
Menard, 2017, Social stress induces neurovascular pathology promoting depression, Nat Neurosci, 20, 1752, 10.1038/s41593-017-0010-3
Michelson, 2007, Addition of atomoxetine for depression incompletely responsive to sertraline: a randomized, double-blind, placebo-controlled study, J Clin Psychiatry, 68, 582, 10.4088/JCP.v68n0414
Milaneschi, 2020, Depression heterogeneity and its biological underpinnings: toward immunometabolic depression, Biol Psychiatry, 88, 369, 10.1016/j.biopsych.2020.01.014
Miller, 2008, Neuroendocrine-immune mechanisms of behavioral comorbidities in patients with cancer, J Clin Oncol, 26, 971, 10.1200/JCO.2007.10.7805
Miller, 2017, Therapeutic implications of brain-immune interactions: treatment in translation, Neuropsychopharmacology, 42, 334, 10.1038/npp.2016.167
Miller, 2013, Cytokine targets in the brain: impact on neurotransmitters and neurocircuits, Depress Anxiety, 30, 297, 10.1002/da.22084
Miller, 2009, Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression, Biol Psychiatry, 65, 732, 10.1016/j.biopsych.2008.11.029
Miller, 2016, The role of inflammation in depression: from evolutionary imperative to modern treatment target, Nat Rev Immunol, 16, 22, 10.1038/nri.2015.5
Mischoulon, 2014, A double-blind, randomized, placebo-controlled clinical trial of S-adenosyl-L-methionine (SAMe) versus escitalopram in major depressive disorder, J Clin Psychiatry, 75, 370, 10.4088/JCP.13m08591
Moaddel, 2018, Plasma metabolomic profiling of a ketamine and placebo crossover trial of major depressive disorder and healthy control subjects, Psychopharmacology (Berl), 235, 3017, 10.1007/s00213-018-4992-7
Mocelin, 2019, N-acetylcysteine reverses anxiety and oxidative damage induced by unpredictable chronic stress in zebrafish, Mol Neurobiol, 56, 1188, 10.1007/s12035-018-1165-y
Mocking, 2016, Meta-analysis and meta-regression of omega-3 polyunsaturated fatty acid supplementation for major depressive disorder, Transl Psychiatry, 6, 10.1038/tp.2016.29
Moieni, 2019, Sex differences in the relationship between inflammation and reward sensitivity: a randomized controlled trial of endotoxin, Biol Psychiatry Cogn Neurosci Neuroimaging, 4, 619
Molero, 2019, Use of non-steroidal anti-inflammatory drugs, aspirin and the risk of depression: the “Seguimiento Universidad de Navarra (SUN)” cohort, J Affect Disord, 247, 161, 10.1016/j.jad.2019.01.020
Moreira, 2019, Metabolic syndrome, depression and anhedonia among young adults, Psychiatry Res, 271, 306, 10.1016/j.psychres.2018.08.009
Mørkholt, 2017, Blocking of carnitine palmitoyl transferase 1 potently reduces stress-induced depression in rat highlighting a pivotal role of lipid metabolism, Sci Rep, 7, 2158, 10.1038/s41598-017-02343-6
Morón, 2003, Mitogen-activated protein kinase regulates dopamine transporter surface expression and dopamine transport capacity, J Neurosci, 23, 8480, 10.1523/JNEUROSCI.23-24-08480.2003
Mostafavi, 2014, Type I interferon signaling genes in recurrent major depression: increased expression detected by whole-blood RNA sequencing, Mol Psychiatry, 19, 1267, 10.1038/mp.2013.161
Moulton, 2018, Repositioning of diabetes treatments for depressive symptoms: a systematic review and meta-analysis of clinical trials, Psychoneuroendocrinology, 94, 91, 10.1016/j.psyneuen.2018.05.010
Muguruma, 2015, Self-organization of polarized cerebellar tissue in 3D culture of human pluripotent stem cells, Cell Rep, 10, 537, 10.1016/j.celrep.2014.12.051
Muscatell, 2016, Exposure to an inflammatory challenge enhances neural sensitivity to negative and positive social feedback, Brain Behav Immun, 57, 21, 10.1016/j.bbi.2016.03.022
Najjar, 2015, Neuroinflammation and white matter pathology in schizophrenia: systematic review, Schizophr Res, 161, 102, 10.1016/j.schres.2014.04.041
Nasca, 2018, Acetyl-l-carnitine deficiency in patients with major depressive disorder, Proc Natl Acad Sci USA, 115, 8627, 10.1073/pnas.1801609115
Nasca, 2017, Role of the astroglial glutamate exchanger xCT in ventral hippocampus in resilience to stress, Neuron, 96, 402, 10.1016/j.neuron.2017.09.020
Nefs, 2012, Suboptimal glycemic control in type 2 diabetes: a key role for anhedonia?, J Psychiatr Res, 46, 549, 10.1016/j.jpsychires.2012.01.013
Nelson, 2009, Atypical antipsychotic augmentation in major depressive disorder: a meta-analysis of placebo-controlled randomized trials, Am J Psychiatry, 166, 980, 10.1176/appi.ajp.2009.09030312
Nicholas, 2019, Fatty acid metabolites combine with reduced β oxidation to activate Th17 inflammation in human type 2 diabetes, Cell Metab, 30, 447, 10.1016/j.cmet.2019.07.004
Notter, 2020, Neuronal activity increases translocator protein (TSPO) levels, Mol Psychiatry
Nunes, 2014, Effort-related motivational effects of the pro-inflammatory cytokine interleukin 1-beta: studies with the concurrent fixed ratio 5/ chow feeding choice task, Psychopharmacology (Berl), 231, 727, 10.1007/s00213-013-3285-4
O’Connor, 2009, Interferon-gamma and tumor necrosis factor-alpha mediate the upregulation of indoleamine 2,3-dioxygenase and the induction of depressive-like behavior in mice in response to bacillus Calmette-Guerin, J Neurosci, 29, 4200, 10.1523/JNEUROSCI.5032-08.2009
O’Connor, 2009, Induction of IDO by bacille Calmette-Guérin is responsible for development of murine depressive-like behavior, J Immunol, 182, 3202, 10.4049/jimmunol.0802722
O’Neill, 2016, A guide to immunometabolism for immunologists, Nat Rev Immunol, 16, 553, 10.1038/nri.2016.70
Olmos, 2014, Tumor necrosis factor alpha: a link between neuroinflammation and excitotoxicity, Mediators Inflamm, 2014, 861231, 10.1155/2014/861231
Ongür, 1998, Glial reduction in the subgenual prefrontal cortex in mood disorders, Proc Natl Acad Sci USA, 95, 13290, 10.1073/pnas.95.22.13290
Osimo, 2019, Prevalence of low-grade inflammation in depression: a systematic review and meta-analysis of CRP levels, Psychol Med, 49, 1958, 10.1017/S0033291719001454
Osimo, 2020, Inflammatory markers in depression: a meta-analysis of mean differences and variability in 5,166 patients and 5,083 controls, Brain Behav Immun, 87, 901, 10.1016/j.bbi.2020.02.010
Pan, 2012, Bidirectional association between depression and metabolic syndrome: a systematic review and meta-analysis of epidemiological studies, Diabetes Care, 35, 1171, 10.2337/dc11-2055
Pan, 2018, Gene expression profile in peripheral blood mononuclear cells of postpartum depression patients, Sci Rep, 8, 10139, 10.1038/s41598-018-28509-4
Pandey, 2017, Inflammatory and innate immune markers of neuroprogression in depressed and teenage suicide brain, Mod Trends Pharmacopsychiatry, 31, 79, 10.1159/000470809
Pandey, 2014, Toll-like receptors in the depressed and suicide brain, J Psychiatr Res, 53, 62, 10.1016/j.jpsychires.2014.01.021
Papakostas, 2010, S-adenosyl methionine (SAMe) augmentation of serotonin reuptake inhibitors for antidepressant nonresponders with major depressive disorder: a double-blind, randomized clinical trial, Am J Psychiatry, 167, 942, 10.1176/appi.ajp.2009.09081198
Papakostas, 2014, Effect of adjunctive L-methylfolate 15 mg among inadequate responders to SSRIs in depressed patients who were stratified by biomarker levels and genotype: results from a randomized clinical trial, J Clin Psychiatry, 75, 855, 10.4088/JCP.13m08947
Papakostas, 2012, L-methylfolate as adjunctive therapy for SSRI-resistant major depression: results of two randomized, double-blind, parallel-sequential trials, Am J Psychiatry, 169, 1267, 10.1176/appi.ajp.2012.11071114
Paredes, 2016, Extensive migration of young neurons into the infant human frontal lobe, Science, 354, aaf7073, 10.1126/science.aaf7073
Park, 2020, A randomized trial of the N-methyl-d-aspartate receptor glycine site antagonist prodrug 4-chlorokynurenine in treatment-resistant depression, Int J Neuropsychopharmacol, 23, 417, 10.1093/ijnp/pyaa025
Parrott, 2016, Neurotoxic kynurenine metabolism is increased in the dorsal hippocampus and drives distinct depressive behaviors during inflammation, Transl Psychiatry, 6, 10.1038/tp.2016.200
Partilla, 2006, Interaction of amphetamines and related compounds at the vesicular monoamine transporter, J Pharmacol Exp Ther, 319, 237, 10.1124/jpet.106.103622
Pary, 2015, A review of psychostimulants for adults with depression, Fed Pract, 32, 30S
Patel, 2016, Bupropion: a systematic review and meta-analysis of effectiveness as an antidepressant, Ther Adv Psychopharmacol, 6, 99, 10.1177/2045125316629071
Patkar, 2006, A randomized, double-blind, placebo-controlled trial of augmentation with an extended release formulation of methylphenidate in outpatients with treatment-resistant depression, J Clin Psychopharmacol, 26, 653, 10.1097/01.jcp.0000246212.03530.fd
Pavlov, 2020, Bioelectronic medicine: from preclinical studies on the inflammatory reflex to new approaches in disease diagnosis and treatment, Cold Spring Harb Perspect Med, 10, a034140, 10.1101/cshperspect.a034140
Pearce, 2013, Metabolic pathways in immune cell activation and quiescence, Immunity, 38, 633, 10.1016/j.immuni.2013.04.005
Pelicano, 2006, Glycolysis inhibition for anticancer treatment, Oncogene, 25, 4633, 10.1038/sj.onc.1209597
Perrin, 2020, Endocrine and immune effects of non-convulsive neurostimulation in depression: a systematic review, Brain Behav Immun, 87, 910, 10.1016/j.bbi.2020.02.016
Petrelli, 2016, Novel insights into gliotransmitters, Curr Opin Pharmacol, 26, 138, 10.1016/j.coph.2015.11.010
Petrulli, 2017, Systemic inflammation enhances stimulant-induced striatal dopamine elevation, Transl Psychiatry, 7, 10.1038/tp.2017.18
Prendergast, 2017, Discovery of IDO1 inhibitors: from bench to bedside, Cancer Res, 77, 6795, 10.1158/0008-5472.CAN-17-2285
Qian, 2016, Brain-region-specific organoids using mini-bioreactors for modeling ZIKV exposure, Cell, 165, 1238, 10.1016/j.cell.2016.04.032
Quan, 2007, Brain-immune communication pathways, Brain Behav Immun, 21, 727, 10.1016/j.bbi.2007.05.005
Raison, 2010, CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression, Mol Psychiatry, 15, 393, 10.1038/mp.2009.116
Raison, 2011, Is depression an inflammatory disorder?, Curr Psychiatry Rep, 13, 467, 10.1007/s11920-011-0232-0
Raison, 2013, The evolutionary significance of depression in pathogen host defense (PATHOS-D), Mol Psychiatry, 18, 15, 10.1038/mp.2012.2
Raison, 2013, A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers, JAMA Psychiatry, 70, 31, 10.1001/2013.jamapsychiatry.4
Rajkowska, 2007, Gliogenesis and glial pathology in depression, CNS Neurol Disord Drug Targets, 6, 219, 10.2174/187152707780619326
Rakic, 2009, Evolution of the neocortex: a perspective from developmental biology, Nat Rev Neurosci, 10, 724, 10.1038/nrn2719
Randall, 2014, Bupropion increases selection of high effort activity in rats tested on a progressive ratio/chow feeding choice procedure: implications for treatment of effort-related motivational symptoms, Int J Neuropsychopharmacol, 18, pyu017, 10.1093/ijnp/pyu017
Rapaport, 2016, Inflammation as a predictive biomarker for response to omega-3 fatty acids in major depressive disorder: a proof-of-concept study, Mol Psychiatry, 21, 71, 10.1038/mp.2015.22
Ravindran, 2008, Osmotic-release oral system methylphenidate augmentation of antidepressant monotherapy in major depressive disorder: results of a double-blind, randomized, placebo-controlled trial, J Clin Psychiatry, 69, 87, 10.4088/JCP.v69n0112
Richards, 2016, Lisdexamfetamine dimesylate augmentation for adults with major depressive disorder and inadequate response to antidepressant monotherapy: Results from 2 phase 3, multicenter, randomized, double-blind, placebo-controlled studies, J Affect Disord, 206, 151, 10.1016/j.jad.2016.07.006
Richards, 2018, PET radioligand binding to translocator protein (TSPO) is increased in unmedicated depressed subjects, EJNMMI Res, 8, 57, 10.1186/s13550-018-0401-9
Ridker, 2003, Clinical application of C-reactive protein for cardiovascular disease detection and prevention, Circulation, 107, 363, 10.1161/01.CIR.0000053730.47739.3C
Rojí, 2017, The use of methylphenidate to relieve fatigue, Curr Opin Support Palliat Care, 11, 299, 10.1097/SPC.0000000000000296
Rooks, 2016, Gut microbiota, metabolites and host immunity, Nat Rev Immunol, 16, 341, 10.1038/nri.2016.42
Rosas-Ballina, 2011, Acetylcholine-synthesizing T cells relay neural signals in a vagus nerve circuit, Science, 334, 98, 10.1126/science.1209985
Rosenblat, 2018, Efficacy and tolerability of minocycline for depression: a systematic review and meta-analysis of clinical trials, J Affect Disord, 227, 219, 10.1016/j.jad.2017.10.042
Rutherford, 2019, Effects of L-DOPA monotherapy on psychomotor speed and [11C]raclopride binding in high-risk older adults with depression, Biol Psychiatry, 86, 221, 10.1016/j.biopsych.2019.04.007
Rutigliano, 2018, The case for TAAR1 as a modulator of central nervous system function, Front Pharmacol, 8, 987, 10.3389/fphar.2017.00987
Salamone, 2012, The mysterious motivational functions of mesolimbic dopamine, Neuron, 76, 470, 10.1016/j.neuron.2012.10.021
Salazar, 2012, Indoleamine 2,3-dioxygenase mediates anhedonia and anxiety-like behaviors caused by peripheral lipopolysaccharide immune challenge, Horm Behav, 62, 202, 10.1016/j.yhbeh.2012.03.010
Salvadore G, Nash A, Bleys C, Hsu B, Saad Z, Gause A, Moyer J, Xi L, Manji H, Van Nueten L, et al. (2018) A double-blind, placebo-controlled, multicenter study of sirukumab as adjunctive treatment to a monoaminergic antidepressant in adults with major depressive disorder, in American College of Neuropsychopharmacology 57th Annual Meeting; 2018 Dec 6; Hollywood, FL.
Sanacora, 2013, From pathophysiology to novel antidepressant drugs: glial contributions to the pathology and treatment of mood disorders, Biol Psychiatry, 73, 1172, 10.1016/j.biopsych.2013.03.032
Sanacora, 2017, Adjunctive lanicemine (AZD6765) in patients with major depressive disorder and history of inadequate response to antidepressants: a randomized, placebo-controlled study, Neuropsychopharmacology, 42, 844, 10.1038/npp.2016.224
Sanacora, 2007, Preliminary evidence of riluzole efficacy in antidepressant-treated patients with residual depressive symptoms, Biol Psychiatry, 61, 822, 10.1016/j.biopsych.2006.08.037
Sanacora, 2012, Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders, Neuropharmacology, 62, 63, 10.1016/j.neuropharm.2011.07.036
Sanada, 2020, Gut microbiota and major depressive disorder: a systematic review and meta-analysis, J Affect Disord, 266, 1, 10.1016/j.jad.2020.01.102
Santos, 2017, Differentiation of inflammation-responsive astrocytes from glial progenitors generated from human induced pluripotent stem cells, Stem Cell Reports, 8, 1757, 10.1016/j.stemcr.2017.05.011
Sarkar, 2010, The immunoregulatory role of dopamine: an update, Brain Behav Immun, 24, 525, 10.1016/j.bbi.2009.10.015
Sarris, 2018, Adjunctive S-adenosylmethionine (SAMe) in treating non-remittent major depressive disorder: an 8-week double-blind, randomized, controlled trial, Eur Neuropsychopharmacol, 28, 1126, 10.1016/j.euroneuro.2018.07.098
Savitz, 2020, The kynurenine pathway: a finger in every pie, Mol Psychiatry, 25, 131, 10.1038/s41380-019-0414-4
Savitz, 2015, Activation of the kynurenine pathway is associated with striatal volume in major depressive disorder, Psychoneuroendocrinology, 62, 54, 10.1016/j.psyneuen.2015.07.609
Savitz, 2013, Inflammation and neurological disease-related genes are differentially expressed in depressed patients with mood disorders and correlate with morphometric and functional imaging abnormalities, Brain Behav Immun, 31, 161, 10.1016/j.bbi.2012.10.007
Savitz, 2018, Treatment of bipolar depression with minocycline and/or aspirin: an adaptive, 2×2 double-blind, randomized, placebo-controlled, phase IIA clinical trial, Transl Psychiatry, 8, 27, 10.1038/s41398-017-0073-7
Schwarcz, 2004, The kynurenine pathway of tryptophan degradation as a drug target, Curr Opin Pharmacol, 4, 12, 10.1016/j.coph.2003.10.006
Sethom, 2010, Polyunsaturated fatty acids deficits are associated with psychotic state and negative symptoms in patients with schizophrenia, Prostaglandins Leukot Essent Fatty Acids, 83, 131, 10.1016/j.plefa.2010.07.001
Setiawan, 2015, Role of translocator protein density, a marker of neuroinflammation, in the brain during major depressive episodes, JAMA Psychiatry, 72, 268, 10.1001/jamapsychiatry.2014.2427
Shafiei, 2012, Acute stress induces selective alterations in cost/benefit decision-making, Neuropsychopharmacology, 37, 2194, 10.1038/npp.2012.69
Shao, 2013, Suppression of neuroinflammation by astrocytic dopamine D2 receptors via αB-crystallin, Nature, 494, 90, 10.1038/nature11748
Shelton, 2010, Eating ourselves to death (and despair): the contribution of adiposity and inflammation to depression, Prog Neurobiol, 91, 275, 10.1016/j.pneurobio.2010.04.004
Shelton, 2015, Association of obesity and inflammatory marker levels on treatment outcome: results from a double-blind, randomized study of adjunctive L-methylfolate calcium in patients with MDD who are inadequate responders to SSRIs, J Clin Psychiatry, 76, 1635, 10.4088/JCP.14m09587
Simanek, 2014, Herpesviruses, inflammatory markers and incident depression in a longitudinal study of Detroit residents, Psychoneuroendocrinology, 50, 139, 10.1016/j.psyneuen.2014.08.002
Singh, 2019, Brain and behavioral correlates of insulin resistance in youth with depression and obesity, Horm Behav, 108, 73, 10.1016/j.yhbeh.2018.03.009
Soczynska, 2012, Novel therapeutic targets in depression: minocycline as a candidate treatment, Behav Brain Res, 235, 302, 10.1016/j.bbr.2012.07.026
Soder, 2020, Dose-response effects of d-amphetamine on effort-based decision-making and reinforcement learning, Neuropsychopharmacology
Soliman, 2017, Pluripotent stem cells in neuropsychiatric disorders, Mol Psychiatry, 22, 1241, 10.1038/mp.2017.40
Song, 2019, Inhibition of hexokinases holds potential as treatment strategy for rheumatoid arthritis, Arthritis Res Ther, 21, 87, 10.1186/s13075-019-1865-3
Spijker, 2010, Stimulated gene expression profiles as a blood marker of major depressive disorder, Biol Psychiatry, 68, 179, 10.1016/j.biopsych.2010.03.017
Stacey, 2018, A gene co-expression module implicating the mitochondrial electron transport chain is associated with long-term response to lithium treatment in bipolar affective disorder, Transl Psychiatry, 8, 183, 10.1038/s41398-018-0237-0
Stachowiak, 2017, Cerebral organoids reveal early cortical maldevelopment in schizophrenia-computational anatomy and genomics, role of FGFR1, Transl Psychiatry, 7, 6, 10.1038/s41398-017-0054-x
Stahl, 2007, Novel therapeutics for depression: L-methylfolate as a trimonoamine modulator and antidepressant-augmenting agent, CNS Spectr, 12, 739, 10.1017/S1092852900015418
Stouffer, 2015, Insulin enhances striatal dopamine release by activating cholinergic interneurons and thereby signals reward, Nat Commun, 6, 8543, 10.1038/ncomms9543
Straub, 2017, The brain and immune system prompt energy shortage in chronic inflammation and ageing, Nat Rev Rheumatol, 13, 743, 10.1038/nrrheum.2017.172
Strawbridge, 2015, Inflammation and clinical response to treatment in depression: a meta-analysis, Eur Neuropsychopharmacol, 25, 1532, 10.1016/j.euroneuro.2015.06.007
Su, 2010, Phospholipase A2 and cyclooxygenase 2 genes influence the risk of interferon-alpha-induced depression by regulating polyunsaturated fatty acids levels, Biol Psychiatry, 67, 550, 10.1016/j.biopsych.2009.11.005
Su, 2019, Interferon-alpha-induced depression: comparisons between early- and late-onset subgroups and with patients with major depressive disorder, Brain Behav Immun, 80, 512, 10.1016/j.bbi.2019.04.032
Su, 2014, Omega-3 fatty acids in the prevention of interferon-alpha-induced depression: results from a randomized, controlled trial, Biol Psychiatry, 76, 559, 10.1016/j.biopsych.2014.01.008
Su, 2019, Comparison of blood lipid profile/thyroid function markers between unipolar and bipolar depressed patients and in depressed patients with anhedonia or suicidal thoughts, Mol Med, 25, 51, 10.1186/s10020-019-0119-9
Swistowski, 2010, Efficient generation of functional dopaminergic neurons from human induced pluripotent stem cells under defined conditions, Stem Cells, 28, 1893, 10.1002/stem.499
Symmonds, 2010, Metabolic state alters economic decision making under risk in humans, PLoS One, 5, 10.1371/journal.pone.0011090
Szollosi, 2018, Current and novel anti-inflammatory drug targets for inhibition of cytokines and leucocyte recruitment in rheumatic diseases, J Pharm Pharmacol, 70, 18, 10.1111/jphp.12811
Sztainert, 2018, Hungry to gamble? Ghrelin as a predictor of persistent gambling in the face of loss, Biol Psychol, 139, 115, 10.1016/j.biopsycho.2018.10.011
Ter Horst, 2018, Striatal dopamine regulates systemic glucose metabolism in humans and mice, Sci Transl Med, 10, eaar3752, 10.1126/scitranslmed.aar3752
Thase, 2006, A double-blind comparison between bupropion XL and venlafaxine XR: sexual functioning, antidepressant efficacy, and tolerability, J Clin Psychopharmacol, 26, 482, 10.1097/01.jcp.0000239790.83707.ab
Thelin, 2020, Delineating astrocytic cytokine responses in a human stem cell model of neural trauma, J Neurotrauma, 37, 93, 10.1089/neu.2019.6480
Tilleux, 2007, Neuroinflammation and regulation of glial glutamate uptake in neurological disorders, J Neurosci Res, 85, 2059, 10.1002/jnr.21325
Tomarken, 2004, Assessing the effects of bupropion SR on mood dimensions of depression, J Affect Disord, 78, 235, 10.1016/S0165-0327(02)00306-3
Torres-Platas, 2014, Morphometric characterization of microglial phenotypes in human cerebral cortex, J Neuroinflammation, 11, 12, 10.1186/1742-2094-11-12
Torres-Platas, 2014, Evidence for increased microglial priming and macrophage recruitment in the dorsal anterior cingulate white matter of depressed suicides, Brain Behav Immun, 42, 50, 10.1016/j.bbi.2014.05.007
Treadway, 2017, Association between interleukin-6 and striatal prediction-error signals following acute stress in healthy female participants, Biol Psychiatry, 82, 570, 10.1016/j.biopsych.2017.02.1183
Treadway, 2012, Effort-based decision-making in major depressive disorder: a translational model of motivational anhedonia, J Abnorm Psychol, 121, 553, 10.1037/a0028813
Treadway, 2019, Can’t or won’t? Immunometabolic constraints on dopaminergic drive, Trends Cogn Sci, 23, 435, 10.1016/j.tics.2019.03.003
Treadway, 2011, Reconsidering anhedonia in depression: lessons from translational neuroscience, Neurosci Biobehav Rev, 35, 537, 10.1016/j.neubiorev.2010.06.006
Trivedi, 2013, A randomized controlled trial of the efficacy and safety of lisdexamfetamine dimesylate as augmentation therapy in adults with residual symptoms of major depressive disorder after treatment with escitalopram, J Clin Psychiatry, 74, 802, 10.4088/JCP.13m08360
Uher, 2014, An inflammatory biomarker as a differential predictor of outcome of depression treatment with escitalopram and nortriptyline, Am J Psychiatry, 171, 1278, 10.1176/appi.ajp.2014.14010094
Vacchelli, 2014, Trial watch: IDO inhibitors in cancer therapy, OncoImmunology, 3
Valkanova, 2013, CRP, IL-6 and depression: a systematic review and meta-analysis of longitudinal studies, J Affect Disord, 150, 736, 10.1016/j.jad.2013.06.004
Veronese, 2018, Aspirin and incident depressive symptoms: a longitudinal cohort study over 8 years, Int J Geriatr Psychiatry, 33, e193, 10.1002/gps.4767
Vichaya, 2018, Inflammation-induced motivational changes: perspective gained by evaluating positive and negative valence systems, Curr Opin Behav Sci, 22, 90, 10.1016/j.cobeha.2018.01.008
Vichaya, 2014, Lipopolysaccharide reduces incentive motivation while boosting preference for high reward in mice, Neuropsychopharmacology, 39, 2884, 10.1038/npp.2014.141
Walker, 2015, Peripheral proinflammatory markers associated with ketamine response in a preclinical model of antidepressant-resistance, Behav Brain Res, 293, 198, 10.1016/j.bbr.2015.07.026
Walker, 2013, NMDA receptor blockade by ketamine abrogates lipopolysaccharide-induced depressive-like behavior in C57BL/6J mice, Neuropsychopharmacology, 38, 1609, 10.1038/npp.2013.71
Walker, 2019, Leucine competes with kynurenine for blood-to-brain transport and prevents lipopolysaccharide-induced depression-like behavior in mice, Mol Psychiatry, 24, 1523, 10.1038/s41380-018-0076-7
Walther, 2018, Lipidomics in major depressive disorder, Front Psychiatry, 9, 459, 10.3389/fpsyt.2018.00459
Wang, 2019, An evolutionary perspective on immunometabolism, Science, 363, eaar3932, 10.1126/science.aar3932
Wang, 2020, Minocycline prevents the depressive-like behavior through inhibiting the release of HMGB1 from microglia and neurons, Brain Behav Immun, 88, 132, 10.1016/j.bbi.2020.06.019
Wang, 2018, HMGB1 mediates depressive behavior induced by chronic stress through activating the kynurenine pathway, Brain Behav Immun, 72, 51, 10.1016/j.bbi.2017.11.017
Wang, 2013, Human iPSC-derived oligodendrocyte progenitor cells can myelinate and rescue a mouse model of congenital hypomyelination, Cell Stem Cell, 12, 252, 10.1016/j.stem.2012.12.002
Warner-Schmidt, 2011, Antidepressant effects of selective serotonin reuptake inhibitors (SSRIs) are attenuated by antiinflammatory drugs in mice and humans, Proc Natl Acad Sci USA, 108, 9262, 10.1073/pnas.1104836108
Warner, 2019, The contribution of the gut microbiome to neurodevelopment and neuropsychiatric disorders, Pediatr Res, 85, 216, 10.1038/s41390-018-0191-9
Weckmann, 2017, Ketamine’s antidepressant effect is mediated by energy metabolism and antioxidant defense system, Sci Rep, 7, 15788, 10.1038/s41598-017-16183-x
Weckmann, 2014, Time-dependent metabolomic profiling of Ketamine drug action reveals hippocampal pathway alterations and biomarker candidates, Transl Psychiatry, 4, 10.1038/tp.2014.119
Westbrook, 2020, Dopamine promotes cognitive effort by biasing the benefits versus costs of cognitive work, Science, 367, 1362, 10.1126/science.aaz5891
Wichers, 2005, Early increase in vegetative symptoms predicts IFN-alpha-induced cognitive-depressive changes, Psychol Med, 35, 433, 10.1017/S0033291704003526
Wilkinson, 2019, A new generation of antidepressants: an update on the pharmaceutical pipeline for novel and rapid-acting therapeutics in mood disorders based on glutamate/GABA neurotransmitter systems, Drug Discov Today, 24, 606, 10.1016/j.drudis.2018.11.007
Wittenberg, 2020, Effects of immunomodulatory drugs on depressive symptoms: A mega-analysis of randomized, placebo-controlled clinical trials in inflammatory disorders, Mol Psychiatry, 25, 1275, 10.1038/s41380-019-0471-8
Wright, 2015, N-Acetylcysteine improves mitochondrial function and ameliorates behavioral deficits in the R6/1 mouse model of Huntington’s disease, Transl Psychiatry, 5, 10.1038/tp.2014.131
Wu, 2007, Kynurenic acid leads, dopamine follows: a new case of volume transmission in the brain?, J Neural Transm (Vienna), 114, 33, 10.1007/s00702-006-0562-y
Xiang, 2017, Adjunctive minocycline for schizophrenia: a meta-analysis of randomized controlled trials, Eur Neuropsychopharmacol, 27, 8, 10.1016/j.euroneuro.2016.11.012
Xiao, 2016, Fatigue is associated with inflammation in patients with head and neck cancer before and after intensity-modulated radiation therapy, Brain Behav Immun, 52, 145, 10.1016/j.bbi.2015.10.016
Xiao, 2017, Depressive symptoms and inflammation are independent risk factors of fatigue in breast cancer survivors, Psychol Med, 47, 1733, 10.1017/S0033291717000150
Xie, 2009, A receptor mechanism for methamphetamine action in dopamine transporter regulation in brain, J Pharmacol Exp Ther, 330, 316, 10.1124/jpet.109.153775
Xie, 2008, Modulation of monoamine transporters by common biogenic amines via trace amine-associated receptor 1 and monoamine autoreceptors in human embryonic kidney 293 cells and brain synaptosomes, J Pharmacol Exp Ther, 325, 629, 10.1124/jpet.107.135079
Xu, 2013, Neurochemical abnormalities in unmedicated bipolar depression and mania: a 2D 1H MRS investigation, Psychiatry Res, 213, 235, 10.1016/j.pscychresns.2013.02.008
Yan, 2015, Dopamine controls systemic inflammation through inhibition of NLRP3 inflammasome, Cell, 160, 62, 10.1016/j.cell.2014.11.047
Yang, 2020, Immune biomarkers alterations in post-traumatic stress disorder: A systematic review and meta-analysis, J Affect Disord, 268, 39, 10.1016/j.jad.2020.02.044
Yang, 2015, Serum interleukin-6 is a predictive biomarker for ketamine’s antidepressant effect in treatment-resistant patients with major depression, Biol Psychiatry, 77, e19, 10.1016/j.biopsych.2014.06.021
Yi, 2012, Blood-based gene expression profiles models for classification of subsyndromal symptomatic depression and major depressive disorder, PLoS One, 7, 10.1371/journal.pone.0031283
Yohn, 2016, Effort-related motivational effects of the pro-inflammatory cytokine interleukin-6: pharmacological and neurochemical characterization, Psychopharmacology (Berl), 233, 3575, 10.1007/s00213-016-4392-9
Yoon, 2009, Decreased glutamate/glutamine levels may mediate cytidine's efficacy in treating bipolar depression: a longitudinal proton magnetic resonance spectroscopy study, Neuropsychopharmacology, 34, 1810, 10.1038/npp.2009.2
Yüksel, 2010, Magnetic resonance spectroscopy studies of glutamate-related abnormalities in mood disorders, Biol Psychiatry, 68, 785, 10.1016/j.biopsych.2010.06.016
Zarate, 2004, An open-label trial of riluzole in patients with treatment-resistant major depression, Am J Psychiatry, 161, 171, 10.1176/appi.ajp.161.1.171
Zeng, 2012, Large-scale cellular-resolution gene profiling in human neocortex reveals species-specific molecular signatures, Cell, 149, 483, 10.1016/j.cell.2012.02.052
Zhao, 2013, Targeting cellular metabolism to improve cancer therapeutics, Cell Death Dis, 4, 10.1038/cddis.2013.60
Zheng, 2016, Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host’s metabolism, Mol Psychiatry, 21, 786, 10.1038/mp.2016.44
Zheng, 2017, Adjunctive celecoxib for schizophrenia: A meta-analysis of randomized, double-blind, placebo-controlled trials, J Psychiatr Res, 92, 139, 10.1016/j.jpsychires.2017.04.004
Zhou, 2015, Atypical antipsychotic augmentation for treatment-resistant depression: a systematic review and network meta-analysis, Int J Neuropsychopharmacol, 18, pyv060, 10.1093/ijnp/pyv060
Zhu, 2006, The proinflammatory cytokines interleukin-1beta and tumor necrosis factor-alpha activate serotonin transporters, Neuropsychopharmacology, 31, 2121, 10.1038/sj.npp.1301029
Zhu, 2010, Interleukin-1 receptor activation by systemic lipopolysaccharide induces behavioral despair linked to MAPK regulation of CNS serotonin transporters, Neuropsychopharmacology, 35, 2510, 10.1038/npp.2010.116
Zoller, 2012, Interferon-alpha therapy in patients with hepatitis C virus infection increases plasma phenylalanine and the phenylalanine to tyrosine ratio, J Interferon Cytokine Res, 32, 216, 10.1089/jir.2011.0093